共 15 条
[1]
Gelfand MS(2015)Ceftolozane/tazobactam therapy of respiratory infections due to multidrug-resistant Clin Infect Dis. 61 853-855
[2]
Cleveland KO(2016)Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia J Clin Pharmacol. 56 56-66
[3]
Xiao AJ(2016)Ceftolozane/tazobactam pharmacokinetics in a critically ill adult receiving continuous renal replacement therapy Pharmacotherapy. 36 e30-e33
[4]
Miller BW(2014)Activity of ceftolozane–tazobactam against a broad spectrum of recent clinical anaerobic isolates. Antimicrob Agents Chemother. 58 1218-1223
[5]
Huntington JA(undefined)undefined undefined undefined undefined-undefined
[6]
Nicolau DP(undefined)undefined undefined undefined undefined-undefined
[7]
Bremmer DN(undefined)undefined undefined undefined undefined-undefined
[8]
Nicolau DP(undefined)undefined undefined undefined undefined-undefined
[9]
Burcham P(undefined)undefined undefined undefined undefined-undefined
[10]
Chunduri A(undefined)undefined undefined undefined undefined-undefined